Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduo in Acne Vulgaris
NCT01149330Phase 4Completed
- Sponsor
- Galderma
- Start
- Jul 2010
- Primary completion
- Mar 2011
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adapalene + benzoyl peroxide in acne vulgaris, sponsored by Galderma. Primary endpoint: Efficacy evaluation at 12 weeks. Started Jul 2010; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01149330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149330.